Ingen Technologies, Inc. 

(Public, OTC:IGNT)   Watch this stock   
Find more results for IGNT

Key stats and ratios

Q3 (Aug '09) 2009
Net profit margin 2583.02% -44080.00%
Operating margin -451.89% -22030.00%
EBITD margin - -21550.00%
Return on average assets 1685.66% -951.17%
Return on average equity - -
Employees 6 -

Address

35193 Avenue "A" Suite-C
Yucaipa, CA 92399
United States - Map
+1-800-2599622 (Phone)
+1-909-7907185 (Fax)

Website links

Ingen Technologies, Inc. discussions

  View all discussions »

Description

Ingen Technologies, Inc. (Ingen Technologies) is an emerging medical device manufacturer. The Company develops, markets and distributes medical technologies and products with applications in the respiratory device markets and the medical diagnostics market, as well as markets in emergency response, aviation, military and consumer markets. The Company’s products include Oxyview and OxyAlert, which are respiratory products and GasAlert, a commercial consumer product using the same technology as OxyAlert. Ingen Technologies is a holding company and its operations are conducted by a subsidiary of the same name.

Officers and directors

Scott R. Sand
Chairman of the Board, Chief Executive Officer
Age: 50
Thomas J. Neavitt
Chief Financial Officer, Secretary
Age: 77
Christopher A. Wirth
Chief Operating Officer, Director
Age: 53
Stephen O'Hara
Managing Director, Director
Age: 55
John Finazzo
Managing Director, Director
Age: 43
Yong Sin Khoo
Director
Age: 44
Curt A. Miedema
Director
Age: 51
Charles E. Vorwaller
Director
Age: 51